Navigation Links
ISMPP and MPIP Announce New Medical Publishing Website

BRIARCLIFF MANOR, N.Y., July 29 /PRNewswire/ -- On July 29, 2010 the International Society for Medical Publication Professionals (ISMPP) and the Medical Publishing Insights and Practices (MPIP) initiative launched a new web page highlighting various MPIP initiatives ( The web page is a valuable resource providing information on the overall MPIP initiative, updating viewers on new or planned activities, and providing access to previous MPIP publications and resources. "The launch of the MPIP web page reflects the growing number of important MPIP activities, and further serves as a resource to the pharmaceutical industry, authors, and journal editors," said Al Weigel, Immediate Past President of ISMPP and MPIP Steering Committee member.

MPIP was founded in 2008 by members of the pharmaceutical industry and ISMPP to elevate trust, transparency, and integrity in publishing industry-sponsored studies. MPIP is a collaboration co-sponsored by Amgen, AstraZeneca, GlaxoSmithKline, Pfizer, and ISMPP. The goals of MPIP are to improve understanding of the issues and challenges faced by journals in publishing industry-sponsored research, and promote more effective partnerships between sponsors and journals to raise standards in medical publishing and expand access to data. "While there are guidelines and initiatives around authorship and publishing of industry-sponsored research, the MPIP initiative provides more practical solutions in an environment of open collaboration and trust," said Bernadette Mansi, Scientific Communications Strategy Head at GlaxoSmithKline and MPIP Steering Committee member.

The MPIP initiative won the Communique Trust and Reputation Award at the recently held Communique Awards in London. The Communique awards recognize excellence and best practice in healthcare communications that ultimately deliver real improvements in healthcare, do the right thing for patients, build trust with stakeholders and enhance industry reputation. According to the judges, "This initiative is about driving best industry practice and reputation - especially around transparency - something that is in the interest of both pharma and their agencies."

For more information on MPIP, and to download the recently published Author Submission Toolkit, go to

About the International Society for Medical Publication Professionals: ISMPP is an independent, non-profit professional association with members from the pharmaceutical, medical device, and biotechnology industries; publication planning and medical communication companies; academia; and medical journal staff, including editors and publishers. Its goals are to support the educational needs of publication professionals and to develop best practices that ensure the rigorous maintenance of all ethical standards for reporting results of medical research. Additional information about ISMPP is available by contacting the organization's Executive Director, Kimberly Goldin (phone: +1 914-945-0507; email:

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at

SOURCE International Society for Medical Publication Professionals
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Applications for the September ISMPP Certified Medical Publication Professional Exam Now Being Accepted
2. ISMPP Reiterates Progress in Medical Publications in Response to Senator Grassleys Report
3. Announcing ISMPP EU 2010 - the First European Meeting of the International Society for Medical Publication Professionals, Royal College of Physicians, London, UK, January 20, 2010
4. ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ
5. ISMPP Supports Best Practices and Transparency in Medical Publications: Better Understanding of Terms Such as Ghostwriting Needed
6. International Society for Medical Publication Professionals (ISMPP) Announces First CMPP Exam Window Closes, Next Opportunity in September
7. Oncolytics Biotech(R) Inc. Announces Second Quarter 2010 Results
8. Angiotech Pharmaceuticals and partner Athersys announce positive results from phase I study of MultiStem(R) in heart attack patients
9. Article One Announces Completion of Funding from Alleghany Corporation
10. Oncothyreon announces second quarter 2010 financial results conference call
11. Ambit Biosciences Announces Transition in Company Leadership
Post Your Comments:
(Date:10/12/2015)... ... October 12, 2015 , ... Spirax Sarco, the leader in products ... CSM-C 600 compact clean steam generator . This unit is a skid ... of HTM2031, HTM2010, and EN285 standards. The CMS-C 600 generator can produce up ...
(Date:10/12/2015)... October 12, 2015 cell surface marker ... by 2022, according to a new report by Grand View ... rise in incidence of oncology diseases and other cell-associated disorders. ... expected to reach USD 6.49 billion by 2022, according to ... in demand can be attributed to rise in incidence of ...
(Date:10/12/2015)... 12, 2015 LabStyle Innovations Corp. ... Solution, today announced its Medical Director, Dr. Moshe ... MobiHealth,s 5th EAI International Conference on Wireless Mobile ... innovations in mobile and wireless technologies," the conference will ... from October 14 - 16, 2015. The conference is ...
(Date:10/12/2015)... ... October 12, 2015 , ... NeuMedics Inc., is a ... retinal diseases that can safely and chronically be administered as an eye drop, announced ... co-hosted by The Cleveland Clinic and taking place October 25th to October 28th at ...
Breaking Biology Technology:
(Date:9/10/2015)... LONDON , Sept. 10, 2015 ... This New Study Reveals Selling Opportunities and Revenue ... What,s the future of biologics, especially new drug ... You will stay ahead with exclusive market data ... can explore trends, developments, results, opportunities and sales ...
(Date:9/10/2015)... -- Pursuant Health has collaborated with health experts ... image-based health risk assessment (HRA) optimized for Pursuant ... assessment quantifies user results into an easily understood ... biological age based on personal health habits, characteristics ... Comprised of age, gender, and risk ...
(Date:9/9/2015)... , Sept. 9, 2015  NuData Security ... and solution-based milestones, furthering the company,s commitment to ... online fraud. NuData Security,s online fraud ... the company,s growth cycle. The product combines continual ... determine good user behavior from fraudulent behavior, allowing ...
Breaking Biology News(10 mins):